HSV-1 reactivation is associated with an increased risk of mortality and pneumonia in critically ill COVID-19 patients.
Antoine MeyerNiccolò BuettiNadhira Houhou-FidouhJuliette PatrierMoustafa Abdel-NabeyPierre JaquetSimona PresenteTiphaine GirardFaiza SayaghStephane RucklyPaul-Henri WickyEtienne de MontmollinLila BouadmaRomain SonnevilleDiane DescampsJean-Francois TimsitPublished in: Critical care (London, England) (2021)
HSV-1 reactivation in critically ill COVID-19 patients was associated with an increased risk of day-60 mortality and HAP/VAP.